Spotlight Growth
No Result
View All Result
Wednesday, February 1, 2023
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener
No Result
View All Result
No Result
View All Result
Home Opinion

These Undervalued Smallcap Warrants May Be Poised For Gains

by admin
December 10, 2018
in Opinion
0
These Undervalued Smallcap Warrants May Be Poised For Gains Spotlight Growth Opinion

These Undervalued Smallcap Warrants May Be Poised For Gains Spotlight Growth Opinion

A warrant is versatile trading instrument which gives investors the right (but not the obligation) to initiate exposure to a stock at a predetermined price at some date in the future.  In this way, warrants are similar to stock options. But warrants differ from stock options because they are issued by the companies themselves and they involve the creation of new shares for future transactions.  

Warrants are sometimes included as part of an IPO as a way of raising confidence or attracting investors to the offering.  A well-known example of a warrant issuance occurred during the government bailout of Chrysler in the 1980s, when the the company included 14.4 million warrants as part of its $1.2 billion federal loan agreement.  The Chrysler warrants came with an exercise price of $13 and were offered when the stock was trading at only $5 per share.  The company may not have though share prices would actually rise that high but the stock actually surged above $30, costing Chrysler $300 million and driving strong gains for taxpayers.

Source: Yahoo Finance
Source: Yahoo Finance

Provectus Biopharmaceuticals, Inc. (OTCMKTS: PVCT) may be in a position to generate even more substantial returns if valuations are able to trade back in-line with their historical averages.  

The Knoxville, Tennessee pharmaceutical company recently announced that they have been granted orphan drug designation (ODD) by the U.S. Food and Drug Administration (FDA) for small molecule oncolytic immunotherapy PV-10.  The treatment is used during neuroblastoma treatments in pediatric solid tumors. Provectus has managed to show significant improvements in its per-share earnings performances over the last two years, and the company is expected to show evidence of profitability over the next few quarters.

The Provectus Biopharmaceuticals warrants trade on the OTC market under the symbol “PVCTW” and are convertible into common stock at a strike price of $0.85.  The expiration date for the warrants is not until June 19, 2020. Provectus has traded with a somewhat volatile history but with current valuations trading at extreme lows, this type of price behavior may actually work in the favor of the bulls.  Positive news releases an improvements in earnings per share increase the chances for profitability in the position.

Source: Yahoo Finance
Source: Yahoo Finance

A similar valuation story can be seen with Optex Systems Holdings, Inc. (OTCMKTS: OPXS), which manufacturers precision optical sighting systems for military and commercial applications.  The company recently announced the addition of over $7 Million in new contracts during the fourth fiscal quarter of 2018.  Most of these contracts deal with the construction of Laser Protected Periscopes but also include deals for Non-Laser Protected Periscopes and various Sighting Systems.

The Optex Systems warrants trade on the OTC market under the symbol “OPXXW” and are convertible into common stock at a strike price of $1.50.  The expiration date for the warrants is not until August 26, 2019. While the stock has seen significant declines during the last decade, consistency in the company’s order backlog suggests that we could see valuations turn up again from their currently depressed levels as we head into next year.

Disclaimer: The author and Spotlight Growth has no positions in any of the stocks mentioned in this article. Nor does either party currently have any relationship, or any other conflicts of interest, with any of the companies mentioned in this article. This content is meant for informational and entertainment purposes only and should not be meant as a recommendation to buy or sell any securities. Please visit a licensed financial representative to determine what investments are right for you.

Article By: Ric Cox

Tags: biopharmaceuticalsbiotechcommon stockeditorialemerging growthinvestinginvestmentmedicalMergermicrocap stocksnewsopinionoptionsotc marketsotc stocksOTC warrantspharmaceuticalspublic companysalesservicessmall cap companiessmall cap stockssmall capssmallcap warrantsSpotlight GrowthSpotlight Growth Stocksstock marketstockstechtechnology stockstradingtreatmentwarrants
  • Trending
  • Comments
  • Latest
Asure Software NASDAQ ASUR Human Capital Management HCM Industry Spotlight Growth

Asure Software (NASDAQ: ASUR) is Expanding to Meet the Rising Demand for Human Capital Management Software

September 27, 2022
OLB Group NASDAQ OLB Cuentas NASDAQ CUEN Partnership Fintech Spotlight Growth

OLB Group (NASDAQ: OLB) and Cuentas (NASDAQ: CUEN) Team Up to Bring Fintech Solutions to Over 32,000 Bodegas Across the United States

October 6, 2022
Siyata Mobile NASDAQ SYTA SYTAW SD7 VK7 Purchase Orders Spotlight Growth

New Purchase Orders for SD7 Rugged Device, VK7, and Other Accessories Boost Siyata Mobile’s Outlook (NASDAQ: SYTA)

December 14, 2021
Telcoin TEL Crypto Spotlight Growth

Telcoin (TEL) Quietly Leads a Crypto Remittance Revolution

June 15, 2021
Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

Cybersecurity Stocks Coming Into Focus Amid High-Profile Attacks

0
Safe-T SFET NASDAQ UN Presentation

Safe-T (NASDAQ: SFET) Has Been Selected to Present at the United Nations’ Office of Information and Communications Technology Event

0
Safe-T Group SFET Q4 FY 2020 Financial Results

Safe-T Group (NASDAQ: SFET) Reports Fourth Quarter and Full Year 2020 Financial Results

0
Safe-T Group NASDAQ SFET FY 2020 Prelim

Safe-T Group Ltd. (NASDAQ: SFET) Estimates Record-High Annual Revenues of Approximately $4.9 Million Representing ~50% Growth YoY 2020

0
Versus Systems NASDAQ VS Resolve Debt Partner AI Gamification Consumer Debt Spotlight Growth

Versus Systems (NASDAQ: VS) and Resolve Debt Partner to Integrated Generative AI and Gamification to Customer Payments and Credit Markets

February 1, 2023
Finding the Most Accurate Technical Analysis Indicator Spotlight Growth

Finding the Most Accurate Technical Analysis Indicator

January 31, 2023
Introduction to Stock Options Trading Educational Spotlight Growth

Introduction to Stock Options

January 31, 2023
Oxbridge Re NASDAQ OXBR SurancePlus Tokenized Reinsurance Contracts Spotlight Growth

Oxbridge Re (NASDAQ: OXBR) Announces Its New Subsidiary SurancePlus: To Issue Tokenized Reinsurance Securities

February 1, 2023
ADVERTISEMENT

Recent News

Versus Systems NASDAQ VS Resolve Debt Partner AI Gamification Consumer Debt Spotlight Growth

Versus Systems (NASDAQ: VS) and Resolve Debt Partner to Integrated Generative AI and Gamification to Customer Payments and Credit Markets

February 1, 2023
Finding the Most Accurate Technical Analysis Indicator Spotlight Growth

Finding the Most Accurate Technical Analysis Indicator

January 31, 2023

Categories

  • Bio/Med/Pharma
  • Cannabis
  • Commodities
  • Consumer Goods
  • Crowdfunding
  • Crypto Cheat Sheets
  • Cryptocurrency
  • Earnings
  • Education
  • Entertainment
  • Financials
  • Market News
  • Opinion
  • Politics
  • Real Estate
  • Split Watch
  • Sponsored
  • Store
  • Technology
  • Uncategorized
  • Venture Capital/Private Equity (VC/PE)

Site Navigation

  • Disclosures
  • Terms Of Service
  • Privacy Policy
  • Contact Us

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

No Result
View All Result
  • Home
  • News
    • Bio/Med/Pharma
    • Cannabis
    • Commodities
    • Consumer Goods
    • Crowdfunding
    • Cryptocurrency
    • Crypto Cheat Sheets
    • Earnings
    • Entertainment
    • Financials
    • Market News
    • Opinion
    • Politics
    • Technology
    • Venture Capital/Private Equity (VC/PE)
  • Video
  • Stock and Crypto Screener

Copyright © 2017-2022 Spotlight Growth. All Right Reserved. Designed by Cool Cat Interactive.

Newsletter Signup

Subscribe to our weekly newsletter below and never miss the latest small/micro-cap analysis and investment news from Spotlight Growth.

Enter your email address

Thanks, I’m not interested